Unfried Ricardo Issler, Krause Luciana Maria Fontanari, Cezimbra Helen Minussi, Pacheco Liliane Souto, Larangeira João Alberto, Ribeiro Tiango Aguiar
Department of and Traumatology, University Hospital of Santa Maria (SOT-HUSM), Federal University of Santa Maria (UFSM), Santa Maria, Brazil.
Master's Course in Health and Life Sciences, Universidade Franciscana (UFN), Santa Maria, Brazil.
Clin Med Insights Arthritis Musculoskelet Disord. 2022 May 4;15:11795441221090344. doi: 10.1177/11795441221090344. eCollection 2022.
Prosthetic joint infection (PJI) is a devastating complication that can affect hip arthroplasty. Its treatment is extremely difficult, and issues regarding the optimal treatment remain unanswered. This study intended to show the effectiveness of the one-stage treatment of PJI.
A retrospective observational cohort study performed from July 2014- August 2018. All patients with suspected PJI were included. Major and minor criteria developed by the International Consensus on Periprosthetic Joint Infection (ICPJI) was used to define infection. Laboratory tests and image exams were performed, and all patients were followed for at least 2 years.
Success rate (2018 ICPJI definition to success) in treatment of PJI using one-stage revision method. Clinical and functional outcomes defined by Harris Hip Score (HHS).
Thirty-one patients were screened and 18 analyzed. 69.85 ± 9.76 years was the mean age. Mean follow-up time was 63.84 ± 18.55 months. Ten patients had acetabular defects and required bone graft reconstruction. Sixteen patients were classified as Tier 1, 1 as Tier 3D, and as 1 Tier 3E. Almost 90% of patients submitted to one-stage revision with acetabulum graft reconstruction were free of infection. The overall infection survival rate was 78.31±6.34 months. and sinus tract were statistically significant in univariate Cox's analysis. The predictor of one-stage revision surgery failure that remained final Cox's regression model was (hazard ratio [HR]: 4.47).
Treatment through one-stage revision surgery associated with 6 months of antimicrobial is a viable option with acceptable results even when bone graft reconstruction is necessary. was a strong predictor of failure in this cohort.
人工关节感染(PJI)是一种可影响髋关节置换术的严重并发症。其治疗极为困难,关于最佳治疗的问题仍未得到解答。本研究旨在展示PJI一期治疗的有效性。
一项回顾性观察队列研究,于2014年7月至2018年8月进行。纳入所有疑似PJI的患者。采用国际人工关节周围感染共识(ICPJI)制定的主要和次要标准来定义感染。进行实验室检查和影像学检查,所有患者至少随访2年。
采用一期翻修方法治疗PJI的成功率(根据2018年ICPJI定义为成功)。由Harris髋关节评分(HHS)定义临床和功能结果。
筛选出31例患者,18例进行分析。平均年龄为69.85±9.76岁。平均随访时间为63.84±18.55个月。10例患者有髋臼缺损,需要植骨重建。16例患者被分类为1级,1例为3D级,1例为3E级。几乎90%接受一期翻修并进行髋臼植骨重建的患者无感染。总体感染存活时间为78.31±6.34个月。在单因素Cox分析中,[具体因素未给出]和窦道具有统计学意义。最终Cox回归模型中,一期翻修手术失败的预测因素是[具体因素未给出](风险比[HR]:4.47)。
即使需要进行植骨重建,通过一期翻修手术联合6个月抗菌治疗也是一种可行的选择,结果可接受。[具体因素未给出]是该队列中失败的一个强预测因素。